Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
This report contains market size and forecasts of Short Bowel Syndrome(SBS) in Global, including the following market information:
Global Short Bowel Syndrome(SBS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Short Bowel Syndrome(SBS) market was valued at 895.2 million in 2021 and is projected to reach US$ 3837 million by 2028, at a CAGR of 23.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Route Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Short Bowel Syndrome(SBS) include Merck, Takeda, Emmaus Medical, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals and Zealand Pharma. etc. In 2021,
The global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Short Bowel Syndrome(SBS) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Short Bowel Syndrome(SBS) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Short Bowel Syndrome(SBS) Market Segment Percentages, by Type, 2021 (%)
- Oral Route
- Parental Route
Global Short Bowel Syndrome(SBS) Market, by Sale Channel, 2017-2022, 2023-2028 ($ millions)
Global Short Bowel Syndrome(SBS) Market Segment Percentages, by Sale Channel, 2021 (%)
- Hospitals
- Clinics
- Retail Pharmacies
Global Short Bowel Syndrome(SBS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Short Bowel Syndrome(SBS) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Short Bowel Syndrome(SBS) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Short Bowel Syndrome(SBS) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Takeda
- Emmaus Medical
- Ardelyx
- Naia Pharmaceuticals
- Nutrinia
- OxThera
- Sancilio Pharmaceuticals
- Zealand Pharma
Short Bowel Syndrome (SBS) Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Short Bowel Syndrome(SBS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sale Channel
1.3 Global Short Bowel Syndrome(SBS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Short Bowel Syndrome(SBS) Overall Market Size
2.1 Global Short Bowel Syndrome(SBS) Market Size: 2021 VS 2028
2.2 Global Short Bowel Syndrome(SBS) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Short Bowel Syndrome(SBS) Players in Global Market
3.2 Top Global Short Bowel Syndrome(SBS) Companies Ranked by Revenue
3.3 Global Short Bowel Syndrome(SBS) Revenue by Companies
3.4 Top 3 and Top 5 Short Bowel Syndrome(SBS) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Short Bowel Syndrome(SBS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Short Bowel Syndrome(SBS) Players in Global Market
3.6.1 List of Global Tier 1 Short Bowel Syndrome(SBS) Companies
3.6.2 List of Global Tier 2 and Tier 3 Short Bowel Syndrome(SBS) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Short Bowel Syndrome(SBS) Market Size Markets, 2021 & 2028
4.1.2 Oral Route
4.1.3 Parental Route
4.2 By Type - Global Short Bowel Syndrome(SBS) Revenue & Forecasts
4.2.1 By Type - Global Short Bowel Syndrome(SBS) Revenue, 2017-2022
4.2.2 By Type - Global Short Bowel Syndrome(SBS) Revenue, 2023-2028
4.2.3 By Type - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Short Bowel Syndrome(SBS) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Retail Pharmacies
5.2 By Sale Channel - Global Short Bowel Syndrome(SBS) Revenue & Forecasts
5.2.1 By Sale Channel - Global Short Bowel Syndrome(SBS) Revenue, 2017-2022
5.2.2 By Sale Channel - Global Short Bowel Syndrome(SBS) Revenue, 2023-2028
5.2.3 By Sale Channel - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Short Bowel Syndrome(SBS) Market Size, 2021 & 2028
6.2 By Region - Global Short Bowel Syndrome(SBS) Revenue & Forecasts
6.2.1 By Region - Global Short Bowel Syndrome(SBS) Revenue, 2017-2022
6.2.2 By Region - Global Short Bowel Syndrome(SBS) Revenue, 2023-2028
6.2.3 By Region - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Short Bowel Syndrome(SBS) Revenue, 2017-2028
6.3.2 US Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.3.3 Canada Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.3.4 Mexico Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Short Bowel Syndrome(SBS) Revenue, 2017-2028
6.4.2 Germany Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4.3 France Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4.4 U.K. Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4.5 Italy Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4.6 Russia Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4.7 Nordic Countries Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.4.8 Benelux Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Short Bowel Syndrome(SBS) Revenue, 2017-2028
6.5.2 China Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.5.3 Japan Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.5.4 South Korea Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.5.5 Southeast Asia Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.5.6 India Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Short Bowel Syndrome(SBS) Revenue, 2017-2028
6.6.2 Brazil Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.6.3 Argentina Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue, 2017-2028
6.7.2 Turkey Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.7.3 Israel Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.7.4 Saudi Arabia Short Bowel Syndrome(SBS) Market Size, 2017-2028
6.7.5 UAE Short Bowel Syndrome(SBS) Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Short Bowel Syndrome(SBS) Major Product Offerings
7.1.4 Merck Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Takeda
7.2.1 Takeda Corporate Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Short Bowel Syndrome(SBS) Major Product Offerings
7.2.4 Takeda Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.2.5 Takeda Key News
7.3 Emmaus Medical
7.3.1 Emmaus Medical Corporate Summary
7.3.2 Emmaus Medical Business Overview
7.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Major Product Offerings
7.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.3.5 Emmaus Medical Key News
7.4 Ardelyx
7.4.1 Ardelyx Corporate Summary
7.4.2 Ardelyx Business Overview
7.4.3 Ardelyx Short Bowel Syndrome(SBS) Major Product Offerings
7.4.4 Ardelyx Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.4.5 Ardelyx Key News
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporate Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Major Product Offerings
7.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.5.5 Naia Pharmaceuticals Key News
7.6 Nutrinia
7.6.1 Nutrinia Corporate Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Short Bowel Syndrome(SBS) Major Product Offerings
7.6.4 Nutrinia Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.6.5 Nutrinia Key News
7.7 OxThera
7.7.1 OxThera Corporate Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Short Bowel Syndrome(SBS) Major Product Offerings
7.7.4 OxThera Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.7.5 OxThera Key News
7.8 Sancilio Pharmaceuticals
7.8.1 Sancilio Pharmaceuticals Corporate Summary
7.8.2 Sancilio Pharmaceuticals Business Overview
7.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Major Product Offerings
7.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.8.5 Sancilio Pharmaceuticals Key News
7.9 Zealand Pharma
7.9.1 Zealand Pharma Corporate Summary
7.9.2 Zealand Pharma Business Overview
7.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Major Product Offerings
7.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Revenue in Global Market (2017-2022)
7.9.5 Zealand Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Short Bowel Syndrome(SBS) Market Opportunities & Trends in Global Market
Table 2. Short Bowel Syndrome(SBS) Market Drivers in Global Market
Table 3. Short Bowel Syndrome(SBS) Market Restraints in Global Market
Table 4. Key Players of Short Bowel Syndrome(SBS) in Global Market
Table 5. Top Short Bowel Syndrome(SBS) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Short Bowel Syndrome(SBS) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Short Bowel Syndrome(SBS) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Short Bowel Syndrome(SBS) Product Type
Table 9. List of Global Tier 1 Short Bowel Syndrome(SBS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Short Bowel Syndrome(SBS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Sale Channel - Global Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Sale Channel - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Sale Channel - Short Bowel Syndrome(SBS) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Short Bowel Syndrome(SBS) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Short Bowel Syndrome(SBS) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Short Bowel Syndrome(SBS) Product Offerings
Table 32. Merck Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 33. Takeda Corporate Summary
Table 34. Takeda Short Bowel Syndrome(SBS) Product Offerings
Table 35. Takeda Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 36. Emmaus Medical Corporate Summary
Table 37. Emmaus Medical Short Bowel Syndrome(SBS) Product Offerings
Table 38. Emmaus Medical Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 39. Ardelyx Corporate Summary
Table 40. Ardelyx Short Bowel Syndrome(SBS) Product Offerings
Table 41. Ardelyx Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 42. Naia Pharmaceuticals Corporate Summary
Table 43. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Product Offerings
Table 44. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 45. Nutrinia Corporate Summary
Table 46. Nutrinia Short Bowel Syndrome(SBS) Product Offerings
Table 47. Nutrinia Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 48. OxThera Corporate Summary
Table 49. OxThera Short Bowel Syndrome(SBS) Product Offerings
Table 50. OxThera Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 51. Sancilio Pharmaceuticals Corporate Summary
Table 52. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Product Offerings
Table 53. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
Table 54. Zealand Pharma Corporate Summary
Table 55. Zealand Pharma Short Bowel Syndrome(SBS) Product Offerings
Table 56. Zealand Pharma Short Bowel Syndrome(SBS) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Short Bowel Syndrome(SBS) Segment by Type in 2021
Figure 2. Short Bowel Syndrome(SBS) Segment by Sale Channel in 2021
Figure 3. Global Short Bowel Syndrome(SBS) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Short Bowel Syndrome(SBS) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Short Bowel Syndrome(SBS) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Short Bowel Syndrome(SBS) Revenue in 2021
Figure 8. By Type - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 9. By Sale Channel - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 12. US Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 16. Germany Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 17. France Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 24. China Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 28. India Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 30. Brazil Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Short Bowel Syndrome(SBS) Revenue Market Share, 2017-2028
Figure 33. Turkey Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Short Bowel Syndrome(SBS) Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Takeda Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Emmaus Medical Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ardelyx Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Nutrinia Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. OxThera Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Zealand Pharma Short Bowel Syndrome(SBS) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period.
The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
Global Lansoprazole Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 102
The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the comp......
Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 88
According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period.
The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
Global Esomeprazole Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 89
The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the comp......
Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 126
Market Overview of Global Irritable Bowel Syndrome (IBS) market:
According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 109
Market Overview of Global Diarrhea Drug market:
According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 96
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 136
Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 113
Market Overview of Global Pentasa (Ulcerative Colitis) market:
According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
